Newsroom

Group picture
News
26.5 million euros for the construction of the Helmholtz Institute for One Health in Greifswald - Martin announces new state funding
Mecklenburg-Western Pomerania's Minister of Science, Bettina Martin, announced today (July 31, 2023) in Greifswald 15 million euros of additional state funding for the construction of the Helmholtz Institute for One Health (HIOH). In the interim laboratories of the HIOH, in the presence of the Rector of the University of Greifswald, Prof Katharina Riedel, and the founding director of the Helmholtz Institute for One Health, Prof Fabian Leendertz, she informed about the extended state funding for the new construction of the research center.
31.07.2023
HIOH
Helicobacter pylori, a pathogen residing in the stomach, is the cause of the most common chronic bacterial infection. ©HZI/Rohde
News
New research collaboration on next-generation vaccines against gastrointestinal mucosal pathogens
The constant rise in antimicrobial resistance (AMR) has a major impact on global public health, urgently requiring novel strategies to prevent and treat bacterial infections. The development of effective vaccines represents an attractive cost-effective alternative to novel antibiotics and would be a game changer for patients. For many bacterial infections, especially those occurring on mucosal sites, no effective vaccines exist. Helicobacter pylori (H. pylori), a pathogen residing in the stomach, is the cause of the most common chronic bacterial infection, affecting half of the world´s population, with a high risk to progress into gastric cancer. Therefore, among other gastrointestinal pathogens, H. pylori was declared as priority neglected AMR target pathogen by the WHO, requiring rapid intervention to counter AMR. Standard-of-care for H. pylori is still an antibiotic therapy combined with a proton pump inhibitor, and thus effective treatment of H. pylori infection is severely hampered by rising AMR.
24.07.2023
HZI Campus
[Translate to English:]
News
Clinical development of two antimicrobial agents funded by Else Kröner-Fresenius Foundation
The Else Kröner-Fresenius Foundation's ForTra gGmbH for Research Transfer—the largest medicine-funding foundation in Germany—supports the legally compliant production of new drug candidates for direct use in first-in-human clinical trials. Five projects—including two antimicrobial drug discovery projects of the German Center for Infection Research (DZIF)—are now being funded with a total of three million euros. One of the funded drug candidates was discovered and co-developed at the Helmholtz Centre for Infection Research (HZI) in Braunschweig.
19.07.2023
HZI Campus
Picture of doctoral award winners
News
Award-winning dissertation on CRISPR-based diagnostics
In his doctoral thesis at the Helmholtz Institute for RNA-based Infection Research (HIRI), Chunlei Jiao has paved the way for the development of the CRISPR-based RNA detection and recording platforms known as LEOPARD and TIGER. LEOPARD is a CRISPR-based method that is highly multiplexable, with the potential to detect a variety of disease-related biomarkers in just one test. On the other hand, TIGER enables the recording of transient cellular events at the single-cell level. The Helmholtz Association honors this outstanding achievement with the Doctoral Prize in the research field Health. The HIRI is a site of the Helmholtz Centre for Infection Research (HZI) in Braunschweig in cooperation with the Julius-Maximilians-Universität (JMU) Würzburg.
17.07.2023
HIRI
Group picture
News
New building for innovation in infection research
With numerous supporters, cooperation partners and companions, the Helmholtz Institute for RNA-based Infection Research (HIRI) Würzburg celebrated its groundbreaking ceremony today, July 6. The institute, a site of the Braunschweig Helmholtz Centre for Infection Research (HZI) founded in 2017 in cooperation with the Julius-Maximilians-Universität (JMU) in the city on the River Main, will have its own building on the Würzburg medical campus. The project is being realized with funds from the Free State of Bavaria, represented by the Bavarian State Ministry of Economic Affairs, Regional Development and Energy, and co-financed by the European Union.In his festive speech, Bavaria's Minister President Markus Söder emphasized the relevance of research funding for the Free State's strategy for the future.
06.07.2023
HIRI
Photo of Prof Josef Penninger
News
Geneticist Josef Penninger becomes new Scientific Director of the Helmholtz Centre for Infection Research
From 1 July 2023, Professor Josef Penninger takes over the Scientific Management of the Helmholtz Centre for Infection Research (HZI). Penninger is internationally renowned for his outstanding contributions to genetic and molecular biology. Joining HZI from the University of British Columbia (Canada), where he had led the Life Sciences Institute, he starts his position as head of the interdisciplinary infection research center in Braunschweig. Penninger is taking over the role of Professor Dirk Heinz, who had led the research center since 2011.
27.06.2023
HZI Campus

HZI in the media

Seuchen aus dem KI-Labor: Kann Künstliche Intelligenz bereits Biowaffen bauen?

... beeindruckendes Ergebnis“, sagt Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (HZI). „Trotzdem schlafe ich momentan noch ...

15.10.2026
|
Der Tagesspiegel
Impfung sinnvoll? Erst Erkältungen, dann Corona und Grippe – So schützen Sie sich

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

14.10.2026
|
DIE WELT
HMN 2026: How crawling motility may be far older than previously thought

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

14.10.2026
|
Health Medicine Network
Neue Empfehlungen der WHO zur COVID-19-Impfung

... in der Abteilung „Virale Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI), hat die WHO als externer ...

13.10.2026
|
DeutschesGesundheitsPortal
Metax brings genome-wide coverage into focus for sharper microbial profiling

tool called Metax, developed by researchers at the Helmholtz Centre for Infection Research (HZI) in Braunschweig and described in the

12.10.2026
|
Bioengineer.org
New Hope for Fighting C. difficile Infections

parts of the microbiome. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University. “We

12.10.2026
|
Technology Networks
HZI erhält 724.000 Euro: Makrophagen sollen Lungenfibrose bekämpfen

... auch gezielte Forschungsmittel an das Helmholtz-Zentrum für Infektionsforschung (HZI): Die Forschungsgruppe von Prof ...

12.10.2026
|
Ad Hoc News
Fieser Magen-Darm-Erreger breitet sich immer stärker aus: Infektionen in England steigen drastisch

... nur in England vor. Laut Angaben des Helmholtz Zentrum für Infektionsforschung ist es dem Erreger ...

12.10.2026
|
Frankfurter Rundschau online
EU fördert Entwicklung von Immunzelltherapie bei Lungenfibrose

... und Belgien. Aus Deutschland sind das Helmholtz-Zentrum für Infektionsforschung (HZI), das Fraunhofer-Institut für Toxikologie und ...

12.10.2026
|
MTA Dialog
Forscher entwickeln Wirkstoff gegen Pockenviren

... weitere Versuche herstellen.

 

Auch das Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig ist beteiligt. Die ...

11.10.2026
|
t-online.de
Warum Ballaststoffe nicht bei jedem gleich wirken

... unterschiedlichen Regionen unterscheidet. Der Forscher vom Helmholtz-Zentrum für Infektionsforschung konnte in seiner Studie zeigen, ...

10.10.2026
|
rbb radioeins
Gut bacteria team up with diet to decide who rules the microbiome

Tawk, Youssef El Mouali and colleagues at the Helmholtz Centre for Infection Research, together with collaborators at the University of

09.10.2026
|
Bioengineer.org

Register now for the HZI newsletter